Gene · 5932
Papers3,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of PARP1 and PAR in ATP-Independent Nucleosome Reorganisation during the DNA Damage Response. | Genes (Basel) | 2022 | 36672853 | PubTator, text mining | PubMed |
| Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours. | Int J Mol Sci | 2022 | 36613762 | PubTator, text mining | PubMed |
| The role of SWI/SNF chromatin remodelers in the repair of DNA double strand breaks and cancer therapy. | Front Cell Dev Biol | 2022 | 36605718 | PubTator, text mining | PubMed |
| Applying multi-omics techniques to the discovery of biomarkers for acute aortic dissection. | Front Cardiovasc Med | 2022 | 36588568 | PubTator, text mining | PubMed |
| The UBE2D ubiquitin conjugating enzymes: Potential regulatory hubs in development, disease and evolution. | Front Cell Dev Biol | 2022 | 36578786 | PubTator, text mining | PubMed |
| SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma. | J Transl Med | 2022 | 36578072 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response Machinery for Lung Cancer Treatment. | Pharmaceuticals (Basel) | 2022 | 36558926 | PubTator, text mining | PubMed |
| Application of Integrated BWM Fuzzy-MARCOS Approach for Coating Material Selection in Tooling Industries. | Materials (Basel) | 2022 | 36556808 | PubTator, text mining | PubMed |
| 53BP1: Keeping It under Control, Even at a Distance from DNA Damage. | Genes (Basel) | 2022 | 36553657 | PubTator, text mining | PubMed |
| TRIP13 Participates in Immediate-Early Sensing of DNA Strand Breaks and ATM Signaling Amplification through MRE11. | Cells | 2022 | 36552858 | PubTator, text mining | PubMed |
| Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker. | Curr Oncol | 2022 | 36547193 | PubTator, text mining | PubMed |
| Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy. | Front Oncol | 2022 | 36531044 | PubTator, text mining | PubMed |
| In Silico and Structure-Based Assessment of Similar Variants Discovered in Tandem Repeats of BRCT Domains of BRCA1 and BARD1 To Characterize the Folding Pattern. | ACS Omega | 2022 | 36530327 | PubTator, text mining | PubMed |
| Sirtuins (SIRTs) As a Novel Target in Gastric Cancer. | Int J Mol Sci | 2022 | 36499440 | PubTator, text mining | PubMed |
| NEDDylated Cullin 3 mediates the adaptive response to topoisomerase 1 inhibitors. | Sci Adv | 2022 | 36490343 | PubTator, text mining | PubMed |
| The BRCA1 BRCT promotes antisense RNA production and double-stranded RNA formation to suppress ribosomal R-loops. | Proc Natl Acad Sci U S A | 2022 | 36490315 | PubTator, text mining | PubMed |
| Arginine methylation of BRD4 by PRMT2/4 governs transcription and DNA repair. | Sci Adv | 2022 | 36475791 | PubTator, text mining | PubMed |
| BRCA1 mediates protein homeostasis through the ubiquitination of PERK and IRE1. | iScience | 2022 | 36471805 | PubTator, text mining | PubMed |
| CCAR2 functions downstream of the Shieldin complex to promote double-strand break end-joining. | Proc Natl Acad Sci U S A | 2022 | 36442094 | PubTator, text mining | PubMed |
| BMN673 Is a PARP Inhibitor with Unique Radiosensitizing Properties: Mechanisms and Potential in Radiation Therapy. | Cancers (Basel) | 2022 | 36428712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5932/papers?page=19